Kymera Therapeutics (NASDAQ:KYMR) jumped 16% on Monday after the company reported promising early-stage clinical results for ...

Investing.com -- Kymera Therapeutics (NASDAQ:KYMR) stock surged 16% after the company announced positive results from its Phase 1b clinical trial of KT-621, an oral STAT6 degrader, in patients with ...

Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.

Any diagnosis can affect romantic relationships, and atopic dermatitis is no exception. Here's how to communicate with your partner about the emotional aspects of living with eczema, balancing life's ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

Children saw improvements in their atopic dermatitis with tapinarof regardless of their atopic comorbidities, according to ...

Please provide your email address to receive an email when new articles are posted on . 40% to 50% of patients with chronic hand eczema have concomitant atopic dermatitis. Differentially expressed ...

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...

Early trial results show stapokibart improves paediatric atopic dermatitis with good tolerability. Find out more about its ...

Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and ...

A new study has shown that, while there is limited evidence for overall increased mortality in patients with atopic eczema, those with severe atopic eczema may have a greater risk of dying from ...

Atopic dermatitis, the most common form of eczema, can lead to a range of complications that go beyond skin issues to include those involving eye health and mental health. People with atopic ...